PLUS THERAPEUTICS, INC. — Director's Dealing 2010

Feb 10, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2010-02-09

Reporting Person: HOLMES E CARMACK (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-02-09	Restricted Stock Award (Common Stock)	A	768	—	Acquired	18401	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-02-09	Non-Qualified Stock Option	$6.84	A	20000	Acquired	2020-02-09	Common Stock (20000)	Direct

Footnotes

F1: The Restricted Stock Award ("Award") vests in full on December 31, 2010, unless Dr. Holmes voluntarily resigns prior to 12/31/10, or if he is nominated, but declines to stand for re-election at the Company's 2010 Annual Meeting. Vesting of the Award will be accelerated upon Dr. Holmes' death or failure to be re-elected at the Company's 2010 Annual Meeting.

F2: These shares are held of record by E. Carmack Holmes & Carolyn K Holmes TTEE, Holmes Living Trust DD 05/15/92.

F3: The Option vests 1/24th per month from date of grant.